
Get every episode summarized
Each time All Things Policy publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Non-communicable diseases (or NCDs) account for nearly two-thirds of the world’s total mortality and morbidity, led by ischaemic heart disease, stroke and diabetes, according to the latest Global Burden of Disease (GBD) report. Globally in 2021, 18 million people died from an NCD before age 70 years. From the period 2021-23, NCDs were responsible for about 56.7 percent of all deaths in India. To help unpack some of the economic impacts of NCDs, particularly the high out-of-pocket expenditures it incurs, Kripa Koshy (Staff Programme Manager, Takshashila) is joined by Merlyn Paul, a PGP graduate and co-founder of Samaagrith, a consulting organisation that aims to make the social impact journey easier.
All Things Policy is a daily podcast on public policy brought to you by the Takshashila Institution, Bengaluru.
Find out more on our research and other work here: https://takshashila.org.in/research-areas
Check out our public policy courses here: https://school.takshashila.org.in
Get every episode summarized
Each time All Things Policy publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Know when Merlyn Paul turns up
Follow Merlyn Paul and once a week we email you every new episode they appeared on — including guest spots the show notes never mention, because we read the transcript.
Follow Merlyn PaulFree. Pick your own day and time.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from All Things Policy

A New Congress, A New Challenge for India-US Ties?
All Things Policy

America Votes | Why should India care?
All Things Policy

The Limits of US-China Cooperation on AI Safety
All Things Policy

The Medical Wild East
All Things Policy